DE2845745A1 - Kombinationsvaccine - Google Patents

Kombinationsvaccine

Info

Publication number
DE2845745A1
DE2845745A1 DE19782845745 DE2845745A DE2845745A1 DE 2845745 A1 DE2845745 A1 DE 2845745A1 DE 19782845745 DE19782845745 DE 19782845745 DE 2845745 A DE2845745 A DE 2845745A DE 2845745 A1 DE2845745 A1 DE 2845745A1
Authority
DE
Germany
Prior art keywords
prp
phosphate
haemophilus influenzae
combination vaccine
influenzae type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19782845745
Other languages
German (de)
English (en)
Other versions
DE2845745C2 (sv
Inventor
Joseph S-C Kuo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/846,466 external-priority patent/US4196192A/en
Priority claimed from US05/846,488 external-priority patent/US4220717A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DE2845745A1 publication Critical patent/DE2845745A1/de
Application granted granted Critical
Publication of DE2845745C2 publication Critical patent/DE2845745C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19782845745 1977-10-28 1978-10-20 Kombinationsvaccine Granted DE2845745A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/846,466 US4196192A (en) 1977-10-28 1977-10-28 Combined Haemophilus influenzae type b and pertussis vaccine
US05/846,488 US4220717A (en) 1977-12-22 1977-12-22 Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.

Publications (2)

Publication Number Publication Date
DE2845745A1 true DE2845745A1 (de) 1979-05-10
DE2845745C2 DE2845745C2 (sv) 1987-10-01

Family

ID=27126641

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782845745 Granted DE2845745A1 (de) 1977-10-28 1978-10-20 Kombinationsvaccine

Country Status (25)

Country Link
JP (1) JPS5480408A (sv)
AR (1) AR218932A1 (sv)
AU (1) AU520902B2 (sv)
BE (1) BE871586A (sv)
CA (1) CA1117866A (sv)
CH (1) CH649781A5 (sv)
DD (1) DD140701A5 (sv)
DE (1) DE2845745A1 (sv)
DK (1) DK154327C (sv)
ES (1) ES474611A1 (sv)
FI (1) FI63674C (sv)
FR (1) FR2407000B1 (sv)
GB (1) GB2007244B (sv)
GR (1) GR73991B (sv)
HU (1) HU178166B (sv)
IE (1) IE47474B1 (sv)
IL (1) IL55433A (sv)
IT (1) IT1107570B (sv)
NL (1) NL7810753A (sv)
NO (1) NO149611C (sv)
NZ (1) NZ188211A (sv)
PH (1) PH15882A (sv)
PL (1) PL210545A1 (sv)
SE (1) SE430753B (sv)
YU (1) YU250878A (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE889979A (fr) * 1981-08-14 1982-02-15 Smith Kline Rit Procede de preparation de polysaccharides bacteriens capsulaires antigeniques purifies, produits obtenus et leur utilisation
CA1209036A (en) * 1982-08-20 1986-08-05 Joseph S.C. Kuo Combined haemophilus influenzae and diphtheria, pertussis, tetanus vaccine
US4744982A (en) * 1982-08-24 1988-05-17 Hunter Kenneth W Human monoclonal antibody reactive with polyribosylribitol phosphate
IL98715A0 (en) * 1990-08-13 1992-07-15 American Cyanamid Co Filamentous hemaglutinin of bodetella pertussis as a carrier molecule for conjugate vaccines
HU9400426D0 (en) * 1991-08-16 1994-05-30 Merck & Co Inc Process for converting lipid-containing bacterial capsular polysaccharide into lipid-free polysaccharide

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1119543A (en) * 1965-01-19 1968-07-10 Merck & Co Inc Antigen preparation and vaccine
US3395219A (en) * 1964-12-11 1968-07-30 Merck & Co Inc Process for production of pertussis antigen
US3465078A (en) * 1965-10-21 1969-09-02 Sydney Z Spiesel Method of recovering antigens from bordetella pertussis cells
FR2043475A1 (sv) * 1969-05-20 1971-02-19 Cassenne Lab Sa
GB1489896A (en) * 1973-12-10 1977-10-26 Fabre Sa Pierre Process for preparing vaccines based on antigens ribosomal fractions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636192A (en) * 1970-01-13 1972-01-18 Us Army Meningococcal polysaccharide vaccines
DE2461439C3 (de) * 1974-12-24 1980-03-20 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines schützenden Antigens von Bordetella Pertussis sowie jenes enthaltendes Mittel
US3978209A (en) * 1975-03-24 1976-08-31 Merck & Co., Inc. Endotoxin free meningococcus polysaccharides

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395219A (en) * 1964-12-11 1968-07-30 Merck & Co Inc Process for production of pertussis antigen
GB1119543A (en) * 1965-01-19 1968-07-10 Merck & Co Inc Antigen preparation and vaccine
US3465078A (en) * 1965-10-21 1969-09-02 Sydney Z Spiesel Method of recovering antigens from bordetella pertussis cells
FR2043475A1 (sv) * 1969-05-20 1971-02-19 Cassenne Lab Sa
GB1489896A (en) * 1973-12-10 1977-10-26 Fabre Sa Pierre Process for preparing vaccines based on antigens ribosomal fractions

Also Published As

Publication number Publication date
NL7810753A (nl) 1979-05-02
FR2407000B1 (sv) 1983-01-21
SE430753B (sv) 1983-12-12
HU178166B (en) 1982-03-28
ES474611A1 (es) 1980-01-16
AU520902B2 (en) 1982-03-04
PH15882A (en) 1983-04-13
DK479578A (da) 1979-04-29
CH649781A5 (de) 1985-06-14
FR2407000A1 (sv) 1979-05-25
BE871586A (fr) 1979-04-27
NO149611C (no) 1984-05-23
GB2007244B (en) 1982-03-31
IL55433A (en) 1982-09-30
AU4108178A (en) 1980-05-01
IE47474B1 (en) 1984-03-21
NO783635L (no) 1979-05-02
GB2007244A (en) 1979-05-16
AR218932A1 (es) 1980-07-15
GR73991B (sv) 1984-06-06
FI63674C (fi) 1983-08-10
DK154327B (da) 1988-11-07
YU250878A (en) 1983-12-31
SE7811192L (sv) 1979-04-29
IL55433A0 (en) 1978-10-31
PL210545A1 (sv) 1980-02-25
IT1107570B (it) 1985-11-25
DE2845745C2 (sv) 1987-10-01
IE782146L (en) 1979-04-28
NZ188211A (en) 1984-09-28
JPS6231694B2 (sv) 1987-07-09
NO149611B (no) 1984-02-13
IT7851621A0 (it) 1978-10-24
JPS5480408A (en) 1979-06-27
FI63674B (fi) 1983-04-29
DK154327C (da) 1989-04-03
FI783269A (fi) 1979-04-29
CA1117866A (en) 1982-02-09
DD140701A5 (de) 1980-03-26

Similar Documents

Publication Publication Date Title
US4220717A (en) Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.
DE69032806T2 (de) Verfahren zur isolierung und reinigung von rezeptoren für transferrin und lactoferrin von bakterien und herstellung von impfstoffen, die sie enthalten
DE68915045T2 (de) Reinigung von Pertussis-Toxinen und Herstellung von Vakzine.
DE69423383T2 (de) Herstellung und Verwendungen von LOS-verminderten Aussenmembran-Proteinen von Gram-negativen Kokken
US4196192A (en) Combined Haemophilus influenzae type b and pertussis vaccine
DE69124235T2 (de) Reinigung und verwendung von pertactin, eines bordetella pertussis aussenmembranproteins
JPS61186328A (ja) 新規錯体
DE69228454T2 (de) Verfahren zum Umwandeln von lipid-haltigen Bakterienkapseln Polysaccharide zu lipid-freien Polysacchariden
EP0220387A2 (de) Konjugatimpfstoffe gegen Infektionen durch gramnegative Bakterien, Verfahren zu deren Herstellung sowie Verwendung derselben
DE69012682T2 (de) Verfahren zur Entfernung von bakteriellen Endotoxinen aus gram-negativen Polysacchariden.
DE69027013T2 (de) Verfahren zur Reinigung eines 69000 Dalton antigenischen Proteins aus Bordetella pertussis
DE3024282A1 (de) Vakzinierende glycopeptid-antigenfraktion mit grosser immunisierungsfaehigkeit, isoliert aus kulturen pathogener keime, verfahren zur isolierung dieser fraktion und diese enthaltende vakzinen
DE2024586B2 (de) Langsame a - und ß - Glykoproteine aus Mikrobenkörpern, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzung
DE69731891T2 (de) Verfahren zur reinigung von gbs-toxin/cm101
DE3787887T2 (de) Verfahren zum Züchten von Bordetella-Pertussis, ein Pertussis-Toxoid und ein Pertussis-Impfstoff.
EP0363835A1 (de) Verwendung von Zink- oder Eisenhydroxid zur Adjuvierung von Antigenlösungen und auf diese Weise adjuvierte Antigenlösungen
DE69026371T2 (de) Heilmittel und verfahren zur inhibierung der vaskularisierung von tumoren
DE3541044A1 (de) Neues, allgemein anwendbares antigen (psc-a) gegen pseudomonas aeruginosa, das als mittel zum schutz gegen pseudomonas aeruginosa-infektion wirkt
DE2845745A1 (de) Kombinationsvaccine
DE3877818T2 (de) Verfahren zur beseitigung von pertussisendotoxin, ein pertussistoxoid und seine herstellung.
DE3152621C2 (sv)
DD202623A5 (de) Verfahren zur herstellung von sporen-polyosiden
DE69025375T2 (de) Verfahren
Penn et al. Isolation of a protective, non-toxic capsular antigen from Pasteurella multocida, types B and E
DE68914362T2 (de) Impfstoff, geeignet zur Verhütung bzw. Kontrolle der durch Haemophilus pleuropneumoniae verursachte Schweinekrankheit und Verfahren zu dessen Herstellung.

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee